Three-dimensional imaging assisted segmentectomy in the treatment of localized bronchiectasis: a retrospective...

Surgical treatment is crucial in managing bronchiectasis. Segmentectomy, although a complex procedure, has become more feasible with advancements in thin-slice CT and three-dimensional imaging. These technologies enhance preoperative anatomical understanding and surgical planning. This study aims to demonstrate the viability of using three-dimensional imaging assistance for treating localized bronchiectasis through segmentectomy.

From 2021 to 2023, a total of 34 patients with bronchiectasis underwent segmentectomy. We collected and then analyzed potential factors including general conditions, preoperative clinical symptoms, surgical procedures, length of postoperative hospital stay, incidence of postoperative complications and postoperative follow-ups.

Of the 34 surgical patients, 8 were men and 26 were women, resulting in a total of 34 operations. The average surgical time for segmentectomy was 157.7 ± 63.4 min. The average intraoperative blood loss was 115.9 ± 107.4 ml. Postoperative tube placement lasted an average of 6.5 ± 2.4 days, with an average drainage volume of 724.7 ± 500.9 ml. The average hospital stay was 8.2 ± 3.4 days. Among these patients, 2 developed pneumothorax and 2 experienced air leaks. Additionally, 4 patients developed pneumonia postoperatively. Over an average follow-up period of 14.3 months, most patients showed symptom improvement, with only two cases of recurrence.

Segmentectomy has acceptable postoperative morbidity, mortality, and outcomes. Therefore, segmentectomy is a viable option for the treatment of localized bronchiectasis.